% alzhub.org library filter % Source: https://alzhub.org/research?author=Sabbagh+MN&institution=I4210145600 % 12 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{curtis2015-25622185, author = {Curtis, C. and Gamez, J. E. and Singh, U. and Sadowsky, C. H. and Villena, T. and Sabbagh, M. N. and Beach, T. G. and Duara, R. and others}, title = {{Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density}}, journal = {JAMA neurology}, year = {2015}, doi = {10.1001/jamaneurol.2014.4144}, pmid = {25622185}, url = {https://doi.org/10.1001/jamaneurol.2014.4144} } @article{galasko2014-24696507, author = {Galasko, D. and Bell, J. and Mancuso, J. Y. and Kupiec, J. W. and Sabbagh, M. N. and van Dyck, C. and Thomas, R. G. and Aisen, P. S. and others}, title = {{Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease}}, journal = {Neurology}, year = {2014}, doi = {10.1212/wnl.0000000000000364}, pmid = {24696507}, url = {https://doi.org/10.1212/wnl.0000000000000364} } @article{sabbagh2011-21192237, author = {Sabbagh, M. N. and Agro, A. and Bell, J. and Aisen, P. S. and Schweizer, E. and Galasko, D.}, title = {{PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease}}, journal = {Alzheimer disease and associated disorders}, year = {2011}, doi = {10.1097/wad.0b013e318204b550}, pmid = {21192237}, url = {https://doi.org/10.1097/wad.0b013e318204b550} } @article{doraiswamy2012-22786606, author = {Doraiswamy, P. M. and Sperling, R. A. and Coleman, R. E. and Johnson, K. A. and Reiman, E. M. and Davis, M. D. and Grundman, M. and Sabbagh, M. N. and others}, title = {{Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study}}, journal = {Neurology}, year = {2012}, doi = {10.1212/wnl.0b013e3182661f74}, pmid = {22786606}, url = {https://doi.org/10.1212/wnl.0b013e3182661f74} } @article{sparks2005-15883262, author = {Sparks, D. L. and Sabbagh, M. N. and Connor, D. J. and Lopez, J. and Launer, L. J. and Browne, P. and Wasser, D. and Johnson-Traver, S. and others}, title = {{Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results}}, journal = {Archives of neurology}, year = {2005}, doi = {10.1001/archneur.62.5.753}, pmid = {15883262}, url = {https://doi.org/10.1001/archneur.62.5.753} } @article{johnson2013-23375563, author = {Johnson, K. A. and Sperling, R. A. and Gidicsin, C. M. and Carmasin, J. S. and Maye, J. E. and Coleman, R. E. and Reiman, E. M. and Sabbagh, M. N. and others}, title = {{Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2013}, doi = {10.1016/j.jalz.2012.10.007}, pmid = {23375563}, url = {https://doi.org/10.1016/j.jalz.2012.10.007} } @article{sparks2006-16866904, author = {Sparks, D. L. and Connor, D. J. and Sabbagh, M. N. and Petersen, R. B. and Lopez, J. and Browne, P.}, title = {{Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial}}, journal = {Acta neurologica Scandinavica. Supplementum}, year = {2006}, doi = {10.1111/j.1600-0404.2006.00690.x}, pmid = {16866904}, url = {https://doi.org/10.1111/j.1600-0404.2006.00690.x} } @article{damian2011-21282950, author = {Damian, A. M. and Jacobson, S. A. and Hentz, J. G. and Belden, C. M. and Shill, H. A. and Sabbagh, M. N. and Caviness, J. N. and Adler, C. H.}, title = {{The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores}}, journal = {Dementia and geriatric cognitive disorders}, year = {2011}, doi = {10.1159/000323867}, pmid = {21282950}, url = {https://doi.org/10.1159/000323867} } @article{doraiswamy2014-24614494, author = {Doraiswamy, P. M. and Sperling, R. A. and Johnson, K. and Reiman, E. M. and Wong, T. Z. and Sabbagh, M. N. and Sadowsky, C. H. and Fleisher, A. S. and others}, title = {{Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study}}, journal = {Molecular psychiatry}, year = {2014}, doi = {10.1038/mp.2014.9}, pmid = {24614494}, url = {https://doi.org/10.1038/mp.2014.9} } @article{yin2020-32457210, author = {Yin, J. and Reiman, E. M. and Beach, T. G. and Serrano, G. E. and Sabbagh, M. N. and Nielsen, M. and Caselli, R. J. and Shi, J.}, title = {{Effect of ApoE isoforms on mitochondria in Alzheimer disease}}, journal = {Neurology}, year = {2020}, doi = {10.1212/wnl.0000000000009582}, pmid = {32457210}, url = {https://doi.org/10.1212/wnl.0000000000009582} } @article{caviness2015-25420672, author = {Caviness, J. N. and Hentz, J. G. and Belden, C. M. and Shill, H. A. and Driver-Dunckley, E. D. and Sabbagh, M. N. and Powell, J. J. and Adler, C. H.}, title = {{Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease}}, journal = {Journal of Parkinson's disease}, year = {2015}, doi = {10.3233/jpd-140480}, pmid = {25420672}, url = {https://doi.org/10.3233/jpd-140480} } @article{sabbagh2011-22084131, author = {Sabbagh, M. N. and Fleisher, A. and Chen, K. and Rogers, J. and Berk, C. and Reiman, E. and Pontecorvo, M. and Mintun, M. and others}, title = {{Positron emission tomography and neuropathologic estimates of fibrillar amyloid-β in a patient with Down syndrome and Alzheimer disease}}, journal = {Archives of neurology}, year = {2011}, doi = {10.1001/archneurol.2011.535}, pmid = {22084131}, url = {https://doi.org/10.1001/archneurol.2011.535} }